Evaluating the Effect of a Standardized Initial Psycho-oncological Consultation on Anxiety, Depression, Quality of Life, and Support Use in Cancer Patients A Patient-Initiated Multicenter Randomized Study
Led by Lindenhofgruppe AG · Updated on 2026-09-02
148
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to assess whether an initial consultation with a psycho-oncological specialist can reduce anxiety and depression, improve quality of life, and increase the use of support services among cancer patients. The study targets patients diagnosed with cancer within the last 3 months who are undergoing or planning systemic oncologic or radiotherapy treatments. Participants are randomly assigned to groups to ensure comparable results, and the study was developed by patients and conducted at multiple hospitals.
Participants in the intervention group will receive a 45-minute initial consultation with a psycho-oncological counsellor followed by a 3-month follow-up contact, along with standard cancer treatment. Those in the control group will receive the current standard psycho-oncological care as practiced locally. Questionnaires are administered at the start, 3 months, and 6 months to gather data.
Throughout the 6-month study, participants will complete regular questionnaires to measure changes in anxiety, depression, quality of life, global distress, and use of psycho-oncological support. Researchers will analyze these outcomes to understand the impact of the initial psycho-oncological contact. The study includes monitoring participants reasons for seeking or not seeking support, and all evaluations are conducted remotely through scheduled follow-ups.
CONDITIONS
Brief Title
What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?
Research Team
J
Janine Antonov, PhD, eMBA
F
Forschungszentrum Lindenhofgruppe
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients diagnosed with cancer within the last 3 months with planned or ongoing systemic oncologic treatment or radiotherapy
Age 18 years or older and legally competent
Able to understand and sign informed consent
Willing and able to complete scheduled follow-up questionnaires
No previous contact with psycho-oncological services
You will not qualify if you...
Severe functional impairment with ECOG Performance Status 3 or 4
Receiving or planned treatments with high toxicity risk (e.g., CAR-T cell therapy, myeloablative therapy)
Insufficient German language skills
Unable to give informed consent
Refusal to participate or unsigned consent
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Intervention Period
Duration - 3 months
Participants receive either an initial psycho-oncological consultation with 3 months follow-up contact or standard psycho-oncological care according to local practice.
One 45-minute consultation plus follow-up contacts as scheduled
Follow-up and Assessment
Duration - 6 months total
Participants complete questionnaires at the start, 3 months, and 6 months to assess anxiety, depression, quality of life, and use of psycho-oncological support.
Questionnaires at baseline, 3 months, and 6 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Phase III Study of Oral Zotiraciclib for Recurrent Malignant Gliomas with IDH1 or IDH2 Mutations
Study of 18F-FAPI-04 PETCT and PETMR Scans for Detecting and Monitoring Various Cancers
18F-grazy-02 PETCT Imaging to Monitor Immunotherapy Responses in Adults with Lung Cancer or Melanoma
Study of 68Ga-NYM096 PETCT Imaging to Measure Tracer Uptake in Different Types of Cancer Including Primary and Metastatic Tumors
PET Imaging Using 68GaGa-Sa-DABI-4 to Detect Stimulator of Interferon Gene Expression in Adults with Cancer
Behavioral Intervention to Help Young LatinoHispanic Men with Cancer Manage Emotions and Life Goals
Prospective Clinical and Biological Database of Cancer Patients Starting Anticancer Immunotherapy
Tracking Immune-Related Side Effects Over Time
Phase I Trial Evaluating Safety and Dose of PA5 Intravenous Treatment for Adults With Advanced Solid Tumors
Online Platform for Sharing Cancer Patient Information
To Support Treatment Decisions and Accelerate Research
Study of a Decision Support Program for Older Adults 60 with Acute Myeloid Leukemia and Their Caregivers
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Physicians' attitudes towards psycho-oncology, perceived barriers, and psychosocial competencies: Indicators of successful implementation of adjunctive psycho-oncological care?
Understanding why cancer patients accept or turn down psycho-oncological support: a prospective observational study including patients' and clinicians' perspectives on communication about distress.